Literature DB >> 21270219

Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.

Raquel Sá-Leão1, Francisco Pinto, Sandra Aguiar, Sónia Nunes, João A Carriço, Nelson Frazão, Natacha Gonçalves-Sousa, José Melo-Cristino, Hermínia de Lencastre, Mário Ramirez.   

Abstract

To estimate the invasive disease potential of serotypes and clones circulating in Portugal before extensive use of the seven-valent pneumococcal conjugate vaccine, we analyzed 475 invasive isolates recovered from children and adults and 769 carriage isolates recovered from children between 2001 and 2003. Isolates were serotyped and genotyped by pulsed-field gel electrophoresis, and a selection of isolates were also characterized by multilocus sequence typing. We found that the diversities of serotypes and genotypes of pneumococci responsible for invasive infections and carriage were identical and that most carried clones could also be detected as causes of invasive disease. Their ability to do so, however, varied substantially. Serotypes 1, 3, 4, 5, 7F, 8, 9N, 9L, 12B, 14, 18C, and 20 were found to have an enhanced propensity to cause invasive disease, while serotypes 6A, 6B, 11A, 15B/C, 16F, 19F, 23F, 34, 35F, and 37 were associated with carriage. In addition, significant differences in invasive disease potential between clones sharing the same serotype were found among several serotypes, namely, 3, 6A, 6B, 11A, 14, 19A, 19F, 22F, 23F, 34, and NT. This heterogeneous behavior of the clones was found irrespective of the serotype's overall invasive disease potential. Our results highlight the importance of the genetic background when analyzing the invasive disease potential of certain serotypes and provide an important baseline for its monitoring following conjugate vaccine use. Continuous surveillance should be maintained, and current research should focus on uncovering the genetic determinants that contribute to the heterogeneity of invasive disease potential of clones sharing the same serotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270219      PMCID: PMC3122870          DOI: 10.1128/JCM.01763-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene.

Authors:  Juan J Calix; Moon H Nahm
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

2.  Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis.

Authors:  Dror S Shouval; David Greenberg; Noga Givon-Lavi; Nurith Porat; Ron Dagan
Journal:  Pediatr Infect Dis J       Date:  2006-07       Impact factor: 2.129

3.  Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes.

Authors:  J A Carriço; C Silva-Costa; J Melo-Cristino; F R Pinto; H de Lencastre; J S Almeida; M Ramirez
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 4.  The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease.

Authors:  Aras Kadioglu; Jeffrey N Weiser; James C Paton; Peter W Andrew
Journal:  Nat Rev Microbiol       Date:  2008-04       Impact factor: 60.633

5.  Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages.

Authors:  Sandra I Aguiar; Francisco R Pinto; Sónia Nunes; Isa Serrano; José Melo-Cristino; Raquel Sá-Leão; Mário Ramirez; Hermínia de Lencastre
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

6.  Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine.

Authors:  R Sá-Leão; S Nunes; A Brito-Avô; N Frazão; A S Simões; M I Crisóstomo; A C S Paulo; J Saldanha; I Santos-Sanches; H de Lencastre
Journal:  Clin Microbiol Infect       Date:  2009-04-23       Impact factor: 8.067

7.  Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.

Authors:  S I Aguiar; I Serrano; F R Pinto; J Melo-Cristino; M Ramirez
Journal:  Clin Microbiol Infect       Date:  2008-09       Impact factor: 8.067

8.  Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach.

Authors:  Alexandre P Francisco; Miguel Bugalho; Mário Ramirez; João A Carriço
Journal:  BMC Bioinformatics       Date:  2009-05-18       Impact factor: 3.169

9.  The presence of the pilus locus is a clonal property among pneumococcal invasive isolates.

Authors:  Sandra I Aguiar; Isa Serrano; Francisco R Pinto; José Melo-Cristino; Mario Ramirez
Journal:  BMC Microbiol       Date:  2008-02-28       Impact factor: 3.605

10.  A confidence interval for the wallace coefficient of concordance and its application to microbial typing methods.

Authors:  Francisco R Pinto; José Melo-Cristino; Mário Ramirez
Journal:  PLoS One       Date:  2008-11-11       Impact factor: 3.240

View more
  40 in total

1.  Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.

Authors:  Allison M Brady; Juan J Calix; Jigui Yu; Kimball Aaron Geno; Gary R Cutter; Moon H Nahm
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

2.  Clonal evolution leading to maintenance of antibiotic resistance rates among colonizing Pneumococci in the PCV7 era in Portugal.

Authors:  Alexandra S Simões; Liliana Pereira; Sónia Nunes; António Brito-Avô; Hermínia de Lencastre; Raquel Sá-Leão
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

3.  Polymicrobial pneumococcal bacteraemia: a case-control study.

Authors:  I Grau; C Ardanuy; M H Schulze; J Liñares; R Pallares
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-04       Impact factor: 3.267

4.  Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children.

Authors:  C Hays; Q Vermee; A Agathine; A Dupuis; E Varon; C Poyart; M-C Ploy; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-20       Impact factor: 3.267

5.  Clonal distribution of common pneumococcal serotypes not included in the 7-valent conjugate vaccine (PCV7): marked differences between two ethnic populations in southern Israel.

Authors:  Nurith Porat; Rachel Benisty; Ronit Trefler; Noga Givon-Lavi; Ron Dagan
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

6.  Estimation of the invasive disease potential of Streptococcus pneumoniae in children by the use of direct capsular typing in clinical specimens.

Authors:  E del Amo; L Selva; M F de Sevilla; P Ciruela; P Brotons; M Triviño; S Hernandez; J J Garcia-Garcia; Á Dominguez; C Muñoz-Almagro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-21       Impact factor: 3.267

7.  Streptococcus pneumoniae Serotypes 9 and 14 Circulating in Brazil over a 23-Year Period Prior to Introduction of the 10-Valent Pneumococcal Conjugate Vaccine: Role of International Clones in the Evolution of Antimicrobial Resistance and Description of a Novel Genotype.

Authors:  Tatiana C A Pinto; Fabíola C O Kegele; Cícero A G Dias; Rosana R Barros; José M Peralta; Vânia L C Merquior; Maria da Gloria Carvalho; Sopio Chochua; Paulina Hawkins; Lesley McGee; Lucia M Teixeira
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

8.  Host-pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study.

Authors:  Jean-Pierre Bedos; Emmanuelle Varon; Raphael Porcher; Pierre Asfar; Yves Le Tulzo; Bruno Megarbane; Armelle Mathonnet; Anthony Dugard; Anne Veinstein; Kader Ouchenir; Shidasp Siami; Jean Reignier; Arnaud Galbois; Joël Cousson; Sébastien Preau; Olivier Baldesi; Jean-Philippe Rigaud; Bertrand Souweine; Benoit Misset; Frederic Jacobs; Florent Dewavrin; Jean-Paul Mira
Journal:  Intensive Care Med       Date:  2018-11-19       Impact factor: 17.440

9.  Serotype 5 pneumococci causing invasive pneumococcal disease outbreaks in Barcelona, Spain (1997 to 2011).

Authors:  Dora Rolo; Asunción Fenoll; Dionísia Fontanals; Nieves Larrosa; Montserrat Giménez; Immaculada Grau; Román Pallarés; Josefina Liñares; Carmen Ardanuy
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

10.  The relevance of pneumococcal serotypes.

Authors:  Chamira Rodrigo; Wei Shen Lim
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.